Farmakokinetiske profiler for raske frivillige forsøgspersoner og patienter med diabetes (type 1 eller 2) viste, at sammenlignet med regular humant insulin var absorptionen af insulin glulisin ca. to gange hurtigere, med en peak koncentration der var ca. to gange større.
Pharmacokinetic profiles in healthy volunteers and diabetes patients (type 1 or 2) demonstrated that absorption of insulin glulisine was about twice as fast with a peak concentration approximately twice as high as compared to regular human insulin.